ULTRACAINE DS FORTE INJ 40 MG
ARTICAINE HYDROCHLORIDE : 40 MG EPINEPHRINE : .01 MG · DIN 00538566 · HOECHST CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is ULTRACAINE DS FORTE INJ?
ULTRACAINE DS FORTE INJ 40 MG contains ARTICAINE HYDROCHLORIDE : 40 MG EPINEPHRINE : .01 MG. It is listed in the Health Canada Drug Product Database under DIN 00538566, held by HOECHST CANADA INC., supplied as LIQUID for BLOCK/INFILTRATION administration. Health Canada currently lists it as cancelled post market, status dated 29-Aug-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00538566 |
|---|---|
| Brand name | ULTRACAINE DS FORTE INJ |
| Generic / active ingredient | ARTICAINE HYDROCHLORIDE : 40 MG EPINEPHRINE : .01 MG |
| Manufacturer | HOECHST CANADA INC. |
| Strength | 40 MG |
| Dosage form | LIQUID |
| Route of administration | BLOCK/INFILTRATION |
| Schedule | Ethical |
| ATC code | N01BB58 ARTICAINE, COMBINATIONS |
| AHFS class | 72:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 29-Aug-1996 |
| Original market date | 1981-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N01BB58 ARTICAINE, COMBINATIONS. 12 of 18 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| 4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML) | 0.005 MG | SOLUTION | DENTSPLY CANADA LIMITED | MARKETED | DIN 02248489 |
| 4% ASTRACAINE DENTAL WITH EPINEPHRINE FORTE 1:100,000 (0.01MG/ML) | 40 MG | SOLUTION | DENTSPLY CANADA LIMITED | MARKETED | DIN 02248488 |
| ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION | 0.009 MG | SOLUTION | PIERREL S.P.A. | MARKETED | DIN 02339536 |
| ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION | 0.018 MG | SOLUTION | PIERREL S.P.A. | MARKETED | DIN 02339544 |
| ORABLOC 1:100,000 | 0.018 MG | SOLUTION | PIERREL S.P.A. | MARKETED | DIN 02361914 |
| ORABLOC 1:200,000 | 40 MG | SOLUTION | PIERREL S.P.A. | MARKETED | DIN 02361906 |
| POSICAINE N | 40 MG | SOLUTION | NOVOCOL PHARMACEUTICAL OF CANADA INC | MARKETED | DIN 02381311 |
| POSICAINE SP | 40 MG | SOLUTION | NOVOCOL PHARMACEUTICAL OF CANADA INC | MARKETED | DIN 02381338 |
| SEPTANEST N | 0.005 MG | SOLUTION | SEPTODONT | MARKETED | DIN 02123371 |
| SEPTANEST SP | 0.01 MG | SOLUTION | SEPTODONT | MARKETED | DIN 02123398 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.